Windtree Therapeutics Inc
WINT
WINT was delisted on the 4th of May, 2017.
33 hedge funds and large institutions have $8M invested in Windtree Therapeutics Inc in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 13 reducing their positions, and 1 closing their positions.
992% more call options, than puts
Call options by funds: $688K | Put options by funds: $63K
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
22% more capital invested
Capital invested by funds: $6.57M → $8M (+$1.42M)
0% more funds holding
Funds holding: 33 → 33 (0)
77% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFWA
Summit Financial Wealth Advisors
Lafayette,
Louisiana
|
+$28.3K |
| 2 |
JP Morgan Chase
New York
|
+$4.35K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$638 |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$437 |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$52 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$301K |
| 2 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$114K |
| 3 |
Millennium Management
New York
|
-$73.1K |
| 4 |
RFS
Rockefeller Financial Services
New York
|
-$53K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$51.1K |
WINT Hedge Fund Activity: Q3 2016 in Review
33 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics Inc (WINT) for Q3 2016, worth a combined $8M — up 22% from $6.57M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new WINT positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 13 trimmed.
The largest buyer was Summit Financial Wealth Advisors, opening a new position worth an estimated $28.3K. The largest seller was Sabby Management, cutting an estimated $301K.
- 33 institutional investors held Windtree Therapeutics Inc (WINT) as of Q3 2016, unchanged from Q2 2016.
- Funds reported $8M of Windtree Therapeutics Inc stock for Q3 2016, up 22% quarter-over-quarter.
- 2 funds opened new Windtree Therapeutics Inc positions in Q3 2016 and 1 closed out, a net change of +1 holder.
- The largest Windtree Therapeutics Inc buyer in Q3 2016 was Summit Financial Wealth Advisors, an estimated $28.3K added.
- The largest Windtree Therapeutics Inc seller in Q3 2016 was Sabby Management, an estimated $301K sold.
Based on aggregated 13F filings for Q3 2016.